• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子束疗法在肝脏恶性肿瘤中的应用。

Proton Beam Therapy in Liver Malignancies.

机构信息

Department of Radiation Oncology, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD, 21201, USA.

Department of Radiation Oncology, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD, 21201, USA.

出版信息

Curr Oncol Rep. 2020 Feb 27;22(3):30. doi: 10.1007/s11912-020-0889-9.

DOI:10.1007/s11912-020-0889-9
PMID:32108284
Abstract

PURPOSE OF REVIEW

Proton beam therapy (PBT) allows for improved sparing of surrounding normal tissues compared with X-ray-based radiation therapy. This is especially important in the setting of liver malignancies, where an increase in integral dose leads to a higher risk of radiation-induced liver disease (RILD) as well as close proximity to vital gastrointestinal (GI) organs.

RECENT FINDINGS

We have data from multiple centers demonstrating that PBT can safely deliver high, ablative doses of radiation therapy conferring excellent local control with good tolerance of treatment. PBT is an effective treatment with longstanding evidence of efficacy that is increasing in availability.

摘要

目的综述

与基于 X 射线的放射治疗相比,质子束治疗(PBT)可更好地保护周围正常组织。在肝脏恶性肿瘤的治疗中,这一点尤为重要,因为积分剂量的增加会导致放射性肝损伤(RILD)的风险增加,并且与重要的胃肠道(GI)器官接近。

最新发现

我们有来自多个中心的数据表明,PBT 可以安全地提供高剂量的消融放射治疗,在治疗中具有良好的耐受性,同时能实现优异的局部控制效果。PBT 是一种有效的治疗方法,其疗效已得到长期证实,并且应用越来越广泛。

相似文献

1
Proton Beam Therapy in Liver Malignancies.质子束疗法在肝脏恶性肿瘤中的应用。
Curr Oncol Rep. 2020 Feb 27;22(3):30. doi: 10.1007/s11912-020-0889-9.
2
Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.肝脏恶性肿瘤分次质子束治疗后的胸壁毒性。
Pract Radiat Oncol. 2018 Jul-Aug;8(4):287-293. doi: 10.1016/j.prro.2017.12.007. Epub 2017 Dec 24.
3
Proton radiotherapy for primary liver cancers.原发性肝癌的质子放射治疗。
Lancet Oncol. 2016 Feb;17(2):e49. doi: 10.1016/S1470-2045(15)00616-6. Epub 2015 Dec 24.
4
Proton beam therapy for tumors of the upper abdomen.质子束疗法治疗上腹部肿瘤。
Br J Radiol. 2020 Mar;93(1107):20190226. doi: 10.1259/bjr.20190226. Epub 2019 Aug 23.
5
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.多机构II期研究:大剂量低分割质子束治疗局部不可切除肝细胞癌和肝内胆管癌患者
J Clin Oncol. 2016 Feb 10;34(5):460-8. doi: 10.1200/JCO.2015.64.2710. Epub 2015 Dec 14.
6
Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.肝癌质子治疗:现状与未来展望。
World J Gastroenterol. 2018 Jul 28;24(28):3090-3100. doi: 10.3748/wjg.v24.i28.3090.
7
Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.质子束放疗治疗肝细胞癌的东西方患者放射性肝损伤的预测因子。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):73-86. doi: 10.1016/j.ijrobp.2019.02.032. Epub 2019 Feb 21.
8
A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.一项关于肝脏肿瘤呼吸门控质子束治疗的前瞻性可行性研究。
Pract Radiat Oncol. 2014 Sep-Oct;4(5):316-322. doi: 10.1016/j.prro.2013.10.002. Epub 2013 Nov 22.
9
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.不可切除肝肿瘤患者的质子束调强放疗:质子协作组多机构前瞻性结果。
Radiat Oncol. 2020 Nov 4;15(1):255. doi: 10.1186/s13014-020-01703-3.
10
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.个体化自适应立体定向体部放疗治疗肝损伤高危患者肝脏肿瘤:一项 2 期临床试验。
JAMA Oncol. 2018 Jan 1;4(1):40-47. doi: 10.1001/jamaoncol.2017.2303.

引用本文的文献

1
Initial Experience With Proton Beam Therapy for Pancreatic Cancer at Shonan Kamakura General Hospital.湘南镰仓综合医院质子束治疗胰腺癌的初步经验。
In Vivo. 2025 Sep-Oct;39(5):3001-3007. doi: 10.21873/invivo.14101.
2
Neutron capture-enhanced proton beam therapy outside the irradiation field: in vitro experiments.照射野外的中子俘获增强质子束疗法:体外实验
BMC Res Notes. 2025 Jul 15;18(1):297. doi: 10.1186/s13104-025-07362-5.
3
Spot-optimization reduces beam delivery time in liver breath hold intensity modulated proton therapy.

本文引用的文献

1
Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.质子束治疗与立体定向体部放疗用于肝细胞癌的比较:实践模式、疗效及生物等效剂量增加的影响
J Gastrointest Oncol. 2019 Oct;10(5):999-1009. doi: 10.21037/jgo.2019.08.03.
2
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.局部不可切除肝细胞癌的质子束治疗结果。
Radiother Oncol. 2019 Apr;133:54-61. doi: 10.1016/j.radonc.2018.10.041. Epub 2019 Jan 16.
3
Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
靶点优化可缩短肝脏屏气调强质子治疗中的射束传输时间。
Phys Imaging Radiat Oncol. 2025 Apr 3;34:100763. doi: 10.1016/j.phro.2025.100763. eCollection 2025 Apr.
4
Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review.支气管内超声引导针吸活检术(EBUS-TBNA)的感染性并发症及临床生物标志物:简要综述
Diagnostics (Basel). 2025 Jan 9;15(2):145. doi: 10.3390/diagnostics15020145.
5
Increased cell killing effect in neutron capture enhanced proton beam therapy.中子俘获增强质子束治疗中细胞杀伤效果的增强。
Sci Rep. 2024 Nov 18;14(1):28484. doi: 10.1038/s41598-024-79045-3.
6
Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.质子束立体定向体部放射治疗及笔形束扫描低分割治疗对晚期肝细胞癌和肝内胆管癌安全有效:单中心经验
J Radiosurg SBRT. 2023;9(1):43-52.
7
Analysis of Performance and Failure Modes of the IROC Proton Liver Phantom.IROC质子肝脏体模的性能与失效模式分析
Int J Part Ther. 2023 Jul 14;10(1):23-31. doi: 10.14338/IJPT-22-00043.1. eCollection 2023 Summer.
8
Relative Biological Effectiveness Values of Spot-scanning Proton Beam Therapy at Shonan Kamakura General Hospital.湘南镰仓综合医院点扫描质子束治疗的相对生物学效应值。
In Vivo. 2023 May-Jun;37(3):1016-1021. doi: 10.21873/invivo.13175.
质子束放疗治疗肝细胞癌的东西方患者放射性肝损伤的预测因子。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):73-86. doi: 10.1016/j.ijrobp.2019.02.032. Epub 2019 Feb 21.
4
A phase I trial of Proton stereotactic body radiation therapy for liver metastases.质子立体定向体部放射治疗肝转移瘤的I期试验。
J Gastrointest Oncol. 2019 Feb;10(1):112-117. doi: 10.21037/jgo.2018.08.17.
5
Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans.质子治疗肝细胞癌的运动效应-4D 稳健优化的笔束扫描计划与双散射计划比较。
Phys Med Biol. 2018 Nov 23;63(23):235006. doi: 10.1088/1361-6560/aaecfc.
6
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.肝癌和肝转移患者的肝脏再放疗。
Pract Radiat Oncol. 2018 Nov-Dec;8(6):414-421. doi: 10.1016/j.prro.2018.04.012. Epub 2018 Apr 26.
7
Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.肝脏肿瘤立体定向体部放射治疗后的局部控制。
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):188-195. doi: 10.1016/j.ijrobp.2017.12.288. Epub 2018 Jan 6.
8
Follow-up study of liver metastasis from breast cancer treated by proton beam therapy.质子束治疗乳腺癌肝转移的随访研究
Mol Clin Oncol. 2017 Jul;7(1):56-60. doi: 10.3892/mco.2017.1283. Epub 2017 Jun 1.
9
Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.肝细胞癌患者重复质子束治疗分析
Radiother Oncol. 2017 May;123(2):240-245. doi: 10.1016/j.radonc.2017.03.004. Epub 2017 Mar 30.
10
Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy.质子束放疗作为双侧结直肠癌肝转移无法进行二期肝切除时的挽救性治疗。
Surgery. 2017 Jun;161(6):1543-1548. doi: 10.1016/j.surg.2016.11.034. Epub 2017 Jan 9.